The UAE operates one of the more tightly regulated pharmaceutical environments in the region, and hormonal therapies used in fertility medicine, including hCG, are classified as prescription-only pharmaceuticals. That means hCG can only be legally obtained, prescribed, and administered within a licensed medical setting, never purchased directly by a consumer.
This classification applies regardless of the reason someone might want hCG. Whether the intended use is legitimate fertility treatment or something else entirely, the regulatory pathway is the same: a physician evaluation, a prescription, and dispensing through a licensed pharmacy or clinic.
The Ministry of Health and Prevention, known as MoHAP, along with emirate-level health authorities such as the Dubai Health Authority and the Department of Health in Abu Dhabi, jointly oversee pharmaceutical licensing, clinic accreditation, and the practice standards that fertility centers must follow. Licensed IVF and fertility clinics operating in the UAE are required to meet these standards before they can offer hormonal treatment protocols to patients.
A deeper look at how this regulatory structure applies specifically to hCG is available in our dedicated article on hCG regulatory status under MoHAP.
Clinic accreditation in the UAE also covers laboratory standards, staff qualifications, and record-keeping requirements, all of which apply to any facility offering hormonal fertility treatment. This layered oversight is designed to ensure that a patient receiving hCG as part of treatment is doing so within a system built around accountability rather than an informal arrangement.
Within a licensed clinic, hCG is one of several hormonal tools physicians may draw on during a fertility treatment cycle, most notably as part of the ovulation induction process discussed in our article on hCG in IVF cycles. Its use is always individualized, monitored through hormone panels and ultrasound, and adjusted by the treating physician rather than following a fixed public protocol.
This is a meaningfully different picture from hCG being marketed or sold as a general-purpose product. In a licensed clinical setting, it exists as one component of a broader, closely monitored treatment plan built around a specific patient.
Because hCG is prescription-controlled, any offer to sell it outside a licensed pharmacy or clinic setting, including through informal online channels, falls outside UAE regulation and carries both legal and health risks, a topic explored further in our article on the legal risks of off-label bodybuilding use of hCG.
Patients considering fertility treatment involving hCG should expect the process to run through a licensed clinic from evaluation through to dispensing, with no legitimate path that bypasses that structure.
REVIVE LAB UAE is a supplier of non-prescription research peptides intended for laboratory and research use, entirely separate from the regulated pharmaceutical and clinical fertility space described here. REVIVE LAB UAE does not sell, stock, or supply hCG in any form and has no role in fertility treatment.